We leverage cutting-edge technologies and specialized expertise to provide services across various research fields, allowing for exploration in diverse topics and domains.
Tailoring our services to meet the specific needs and goals of our clients, we aim to deliver customized solutions that lead to optimal research outcomes.
In complex human cell models, molecular workflows must perform beyond basic editing or gene delivery. Genetic modifications influence differentiation efficiency, pathway fidelity, and phenotype stability across experiments. Lambda Biologics develops molecular biology workflows that prioritize genetic accuracy, reproducibility, and downstream compatibility, supporting translational research and New Approach Methodologies (NAMs).
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Our molecular biology services support research programs using human cell lines, iPSC-derived systems, and organoid-based models, where genetic precision and consistency are critical to experimental success.
Contact our team to discuss technical requirements and project scope.
Our service portfolio includes CRISPR-Cas9 gene editing, iPSC generation from somatic cells, and viral vector cloning. These capabilities support the creation of genetically defined human cell systems for in vitro research.
Molecular biology services support human cell lines and induced pluripotent stem cells (iPSC). Project scope and feasibility depend on the specific cell type, genetic target, and intended downstream application.
Each project follows defined quality control steps, including validation of genetic modifications and assessment of genomic integrity. Validation strategies are aligned with the specific molecular approach used.
The molecular biology workflows are designed to be compatible with downstream differentiation workflows and advanced in vitro model development, including organoid-based systems.
Projects are conducted as collaborative technical services with defined milestones, documentation, and communication throughout the workflow to support reproducibility and transparency.
